In veterinary oncologic specimens, histopathology is the gold standard for determining adequacy of excision. Despite limitations of this technique, the pathologist's interpretation of margin status significantly impacts patient management, including indications for adjuvant therapy. This article aims to summarize peer-reviewed literature as it relates to histologic margin evaluation in veterinary cancer patients. The value of histologic tumour-free margins and technical factors influencing histopathologic margin outcomes are also discussed. We review alternative strategies for determining excisional status, and discuss how an evolving understanding of tumour biology might inform clinical and research perspectives on surgical margins. In doing so, we aim to provide context and a stimulus for future investigations into this important yet incompletely understood topic.
Introduction
Introduced in the late 19th century, Halsted's oncologic concept of systematic 'centrifugal' tumour growth forms the basis of the belief that a surgeon must remove all the tumour in order to cure the patient. 1 Although our understanding of cancer has evolved, modern day recommended treatment of locally invasive malignancies often involves wide or radical surgical excision. 2 In general, this approach is supported by the peer-reviewed veterinary literature, with many studies reporting prolonged survival and/or decreased local recurrence with histologically complete excision compared with incomplete surgical margins. However, examples of tumour recurrence despite histologically complete removal, as well as tumours that do not recur in the face of incomplete excision, are encountered both in clinical practice and in the literature.
This leaves surgeons questioning what extent of surgical margins is necessary when treating oncologic patients. This review summarizes relevant veterinary publications on the topic of margin evaluation, draws parallels to select human surgical * Both authors contributed equally to this work. margin literature, and discusses strategies that may improve patient management through an expanding understanding of tumour biology relating to surgical margins. the cut edge. 5, 6 Another group defined 'complete' excision as >2 mm of normal tissue between the tumour and inked edges in all directions. 7 Furthermore, some publications use the word 'margin' to refer to the HTFM, whereas others use 'margin' to refer to the grossly normal surgical margin taken intra-operatively.
5,7 -10 While the HTFM is derived from the grossly normal surgical margin, these represent two different time points with different methods of determining what length of the margin is tumour-free (i.e. gross evaluation intra-operatively versus microscopic evaluation during HTFM measurement) and therefore should not be confused (e.g. a 30 mm grossly normal surgical margin cannot be expected to yield an HTFM of 30 mm). Collectively, these examples illustrate the need for uniformity and clarity in margin reporting and support the recent recommendations for quantifying HTFM (e.g. in millimetres) along with a description of the margin tissue composition. 3 In comparison, human cancer resections have been categorized according to the R-classification system where R0 is a resection with surgical margins that are both macroscopically and microscopically negative for tumour cells (i.e. HTFM > 0 mm), R1 involves a surgical margin which has microscopic evidence of neoplastic cells (i.e. HTFM = 0 mm) but is macroscopically normal, and R2 describes an intra-lesional tumour resection (i.e. macroscopic residual tumour). 11 Although this margin classification scheme has been suggested as useful in clinical practice, an alternative scheme has been proposed by the Union for International Cancer COntrol (UICC; previously named International Union against Cancer) in which R0 is a resection with HTFMs of ≥1 mm, R1 is a resection with an HTFM <1 mm, and R2 describes an intra-lesional tumour resection. 12 A recent study comparing these two classification systems among 265 histologically confirmed human soft tissue sarcoma patients showed lower recurrence rates using the UICC-classification scheme compared with the original R-classification scheme. 13 However, after multivariate analysis, R1 resections of either classification system were the only variables found to be associated with higher risk of local recurrence (UICC R1 resections had a hazard ratio of 15.6 versus original R1 resection had a hazard ratio of 11.2 for local recurrence). Similar clinically validated margin classification schemes have not been established for veterinary cancer patients.
Surgical margins in veterinary surgical oncology
The histologic status of surgical margins in a variety of locally invasive malignant tumour types is prognostic for both dogs and cats. Although these studies encapsulate a multifarious array of margin assessment methods and criteria, they are all based upon light microscopic identification of phenotypically identifiable neoplastic cells in relation to a histologically defined surgical margin. Examples of tumour types that illustrate this concept include: canine mast cell tumour (MCT), canine soft tissue sarcoma (STS), canine squamous cell carcinoma (SCC), canine oral malignant melanoma (MM), and feline injection site sarcoma (ISS).
Canine MCT
Surgical margins in canine MCTs are discussed in many publications, with most studies reporting positive associations between histologically complete surgical margins and improved patient outcomes. 4,5,7,14 -17 For example, in a series of 114 cutaneous MCT from 100 dogs, the authors found no recurrence of tumour or metastatic disease following excision with lateral margins ≥10 mm and deep margins ≥4 mm. 15 A prospective clinical study evaluating a variety of clinical and histopathologic factors for an association with recurrence-free interval after excision of cutaneous MCT, STS and carcinomas found that histologic classification of margin status emerged as the best predictive factor across all tumour types upon multivariate analysis. 7 In this study, univariate analysis found dogs with completely excised MCT experienced a significantly longer recurrence-free interval compared with those with incomplete or 'close' margins (669 ± 193 versus 429 ± 285 days, respectively; P = 0.032). 7 However, these findings should be interpreted in the context of the limitations of the study: small sample size with atypically high recurrence rates, analysis of grades II and III tumours as a single group, and inclusion of injection site sarcomas with other soft tissue sarcomas. In contrast, some other studies have documented no association between margin status and local recurrence, despite a lack of adjuvant post-operative therapy. 9, 18, 19 The most recent of these found that high grade tumours displayed a 36% recurrence rate, despite a median narrowest HTFM of 4 mm. 19 This study reported that after multivariate analysis, only histologic grade was predictive of local recurrence (high-grade tumours had 13.7 greater odds of recurrence compared with low-grade tumours) with the effect of margin status, along with other factors, not remaining significant. 19 A major consideration when interpreting this study is that dogs with incompletely excised (HTFM = 0 mm) tumours were excluded, precluding the ability of this study to detect the clinical significance of incomplete excision. A previous retrospective study supports the importance of histologic grade as being predictive of local recurrence, reporting that 19% of grade III MCTs, 6% of grade II MCTs and only 1% of grade I MCTs regrew during the study period. 4 This study did include incompletely excised tumours (39%), although a multivariate analysis was not performed to determine the relative importance of margin status and histologic grade on regrowth. Finally, a retrospective study specifically designed to evaluate recurrence rates for incompletely excised grade II cutaneous MCT documented recurrence in only 23% of cases.
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Canine STS
Some canine STS studies have shown complete surgical excision confers prognostic advantages. 10, 20, 21 In a landmark canine STS study, dogs with incomplete margins were 10.5 times more likely to experience local recurrence than dogs with complete margins. 21 A study of 37 low-grade canine STS of the appendages reported recurrence in 4 of 24 tumours that had 'dirty' or 'clean but close' surgical margins and 0 of 11 tumours that had 'clean' surgical margins, although this difference did not reach statistical significance. 10 At the same time, this study also documented no recurrence despite histologically incomplete margins in 10 of 12 tumours with a median follow-up time of 408 days, suggesting margin status may be less relevant to clinical outcomes in low-grade STS of the appendages. 10 This is consistent with a previous report in which 26 of 36 dogs with incompletely excised STS did not experience recurrence with follow up ranging from 210 to 2202 days. 21 As with MCT, tumour grade in STS appears to influence local recurrence risk: for marginally excised tumours, recurrence of grade 2 tumours is significantly higher than grade 1 tumours and tumours with a mitotic index >9 also have significantly greater risk of recurrence in comparison to those with a mitotic index ≤5. 20 In the same study, none of the 30 completely excised tumours recurred, regardless of tumour grade. 20 
Canine SCC
Squamous cell carcinoma is considered a locally invasive malignant neoplasm, with prognosis varying by anatomic location. In a report of 17 dogs with nasal planum SCC, recurrence was noted in one of five cases with complete histologic margins versus eight of eight cases with incomplete excision. 22 Digital SCC has been reported to have higher recurrence rate with incomplete or marginal excision. 23 A study with 20 cutaneous carcinomas, which included SCC, found that seven of eight cases with histologically incomplete margins experienced recurrence compared with zero of nine cases with histologically complete margins. 7 Combing data from a pair of historic reports on oral tumours in dogs reveals that oral SCC lesions resected with histologically complete margins recurred in 2 of 12 (17%) cases compared to 4 of 7 (57%) cases with incompletely resected tumours (chi-square, P = 0.067). 24, 25 The same studies reported that dogs with incompletely excised oral tumours (not dividing by tumour type) were 2.4-3.6 times more likely to die of their disease compared with dogs with complete margins.
Canine oral MM
A retrospective study of 70 dogs undergoing curative-intent wide surgical excision of oral MM found no association between incomplete excision and reduced survival time or progression-free interval. 26 In that study, 19 of 70 (27.1%) dogs had histologically incomplete excision with no significant difference in median progression-free interval compared with dogs with complete histologic margins (446 versus >2310 days, respectively; P = 0.19). 26 Determining the significance of margin status from this study is complicated by selection bias introduced by their cohort (i.e. no tumours with conservative excisions were included). Combining data from a pair of historic reports on oral tumours in dogs reveals that oral MM lesions resected with histologically complete margins recurred in 3 of 20 (15%) cases compared to 1 of 7 (14%) cases with incompletely resected tumours (chi-square, P = 0.963). 24, 25 Two additional studies reported compatible findings. 27, 28 However, one of these did determine that wide resection improved survival time when compared with conservative resections that did not include underlying bone, supporting the concept that curative-intent wide surgical resection likely confers a survival advantage for this tumour type. 28 
Feline ISS
Feline ISS is considered one of the most locally aggressive neoplasms encountered in veterinary medicine, as exemplified by a recent publication reporting that 5 cm lateral surgical margins (with two fascial planes deep) yielded reduced local recurrence rates compared to historical reports that used 2-3 cm lateral surgical margins. 8 Other studies have documented lower recurrence rates (19-22%) with histologically complete surgical margins compared to incomplete excision (58-69%). 29, 30 In the study, describing 5 cm lateral surgical margins, local recurrence was still identified in 13 of 91 (14%) cats; only one of these had histologically identified incomplete margins. 8 In summary, it is reasonable to conclude that while complete surgical excision is desirable, there is evidence across multiple tumour types that histologic margin status alone does not fully explain the inconsistent clinical outcomes observed. Current data suggests that recurrence patterns are multifactorial and may depend on additional mechanisms, which may be divided into technical limitations of routine histopathology and factors associated with tumour biology.
Technical limitations of histologic margin evaluation
Although histopathology is widely used for determining adequacy of excision, there is an incomplete understanding of the technical factors that influence margin interpretation. Generating tissue for histopathology involves five broad phases: (1) the immediate post-excisional period, (2) tissue fixation, (3) trimming (sectioning of the fixed gross specimen so that tissue adequately fits into a cassette), (4) histologic processing (post-fixation processing, microtomy and slide mounting), and (5) morphologic slide evaluation. Many of these might impact the pathologist's ability to collect reliable binary (e.g. complete versus incomplete) and continuous data (e.g. HTFM length).
Immediate post-excision period
Physical tissue length reduction (often termed 'shrinkage') occurs due to myofibril contractility and tissue elasticity as tissues are released from surrounding structures (Fig. 1) . 31, 32 This physical length reduction is perhaps the most overt and well-studied technical issue affecting histologic margin assessment. To date, the largest veterinary study evaluating ex vivo tissue changes from 216 normal skin samples measured in 4 directions collected from multiple anatomic sites, showed that the majority of shrinkage occurred immediately after excision, prior to formalin fixation. 32 Mean overall shrinkage was 15.6% in that study and surgeon, body side or region, and skin tension lines did not significantly correlate to percentage of skin shrinkage. An earlier study evaluated the effect of including underlying muscle or fascia on shrinkage and found that tissues both shrank and increased in thickness by as much as 32% and 76%, respectively, with differing results if muscle was included in the sample. 33 Two studies using normal feline skin also documented that most tissue shrinkage occurred immediately following surgical excision, prior to formalin fixation. 34, 35 Importantly, although post-excisional physical tissue length reduction is consistently observed, and is likely to impact HTFM length, this physical effect alone is unlikely to produce a HTFM of zero. In order to validate HTFM as a clinically relevant data A few recent studies have begun to broach this issue in the veterinary literature. A retrospective comparison of intra-operative grossly normal surgical margins and HTFM in canine MCT reported a mean length reduction ranging from 35 to 42%. 36 This change was attributed to physical tissue contraction and/or microscopic tumour infiltration into the peritumoural tissue; however, due to the retrospective nature of this study, the relative contributions of either of these effects were unresolved. A prospective pilot study in feline ISS measured the margin length at multiple time points, from surgery to slide, thereby allowing quantification of margin length reduction because of tissue elasticity (i.e. shrinkage) versus further length reduction after formalin fixation. 37 This small study (20 margins from 5 cats) reported significant decreases in surgical margin length at two time points: immediately following excision (explained by tissue elasticity and recoil following transection; mean 11.9 mm) and upon microscopic evaluation of the slide by the pathologist (reflecting tumour infiltration into surrounding tissues that could not be appreciated grossly; mean 2.8 mm). Considerations for future studies include larger sample sizes to allow for stratification by tumour type, grade, size, stage and/or location, as well as potential use of Mohs surgical techniques. The latter has been performed in at least one canine MCT but is not routinely available at most veterinary surgical centres. 38 Application of inks to surgical margins is recommended to provide tissue orientation and enable accurate histologic identification of a true surgical margin. 3 In spite of consistent ink application methods, ink is still capable of dissecting along fascial planes or inadvertently adhering to other surfaces. A pilot study of normal cadaveric canine skin found that ink dissection or inappropriate ink distribution occurs in 28.1% and in 68.1% of samples, respectively. 39 The performance of inks is not equal between colours and manufacturers; generally purple and red inks are difficult to identify in hematoxylin and eosin stained slides and should be avoided. 40 Collectively this suggests that surgical margin ink, although useful for the reasons mentioned above, has the potential to confound interpretation of a histologic surgical margin. Opportunities may exist for refining this technical aspect of histologic processing to ensure accurate and repeatable histologic margin interpretation.
Tissue fixation
Routine diagnostic specimens are fixed in 10% neutral buffered formalin. Most commercial formalin solutions contain 3.7% formaldehyde in water with 1% methanol. 41 Aldehydes are non-coagulant fixatives that act by cross-linking proteins. 41, 42 Effective tissue fixation requires both penetration and fixation, and is influenced by temperature, pH (and buffering), volume of solution, duration of fixation, tissue type and surface area. 41, 43 Current evidence suggests that skin length reduction due to formalin fixation is minimal, although there may be site specific differences with samples becoming variably thicker (ranging from 45 to 76%) depending on tissues included in the specimen. 31 -35,44 Finally, incompletely fixed specimens, or those fixed at different temperatures, may have different characteristics that could limit accurate tissue morphometry. 45 In addition to the physical effect of shrinkage as discussed above, fixed tissues commonly have three-dimensional distortions with a contour that considerably differs from the fresh ex vivo specimen (Fig. 2) . A recent study attempted to limit these changes by suturing the various tissue layers at the cut surgical margin (e.g. skin, muscle, fascia) in either a simple interrupted or continuous pattern and found this did not significantly reduce the length changes observed following excision, although it did preserve rotational orientation and prevented tissue layer separation of the specimens. 46 
Trimming and sectioning
Recommended sectioning techniques have been summarized in the recent veterinary literature. 3 In order to quantify HTFM measurements, tissue specimens are typically trimmed radially (tissue sections taken from a central axis to the inked circumference). Four complete radial sections can represent HTFM in five directions of interest (e.g. cranial, caudal, dorsal, ventral and deep). Radial sections represent a small proportion of the total surgical margin and fail to take into account irregularities in tumour geometry. 3 HTFM might be influenced by the number of sections performed. One study of desmoid-type fibromatosis in humans found that the probability of documenting a positive margin increased with the number of tissue sections submitted (OR 1.16). 47 Parallel incisions at regular intervals ('bread loafing') are an alternative trimming strategy; widespread veterinary application has been limited by cost. 3 Although this might be a more sensitive technique for detecting neoplastic infiltration of surgical margins, human literature suggests that 'false negative' margins are still frequent. 48, 49 Basal cell carcinomas sectioned using a 4 mm breadloaf model are only 44% sensitive in detecting residual tumour. 48 One publication estimated that for melanoma in situ, breadloafing at 1, 2, 4 and 10 mm intervals would have a 58, 37, 19 and 7% chance of detecting positive margins respectively. 49 As illustrated in the sentinel lymph node literature, detection sensitivity might be improved by serial sections and special techniques. 48 -51 Immunohistochemistry for keratin proteins on sentinel lymph nodes from women with breast cancer finds metastatic disease in 18% of axillary lymph nodes that are negative on routine histopathology. 50 Recent literature suggests this same concept is also applicable to identification of canine metastatic carcinomas. 51 Tangential ('en face') sections do not allow quantification of HTFM but offer a more thorough evaluation of the cut surgical margin. A study of breast conserving surgery in humans demonstrated that tangential sections more frequently identified positive margins compared with radial sections (49 and 15%, respectively). 52 Even extensive tangential sectioning does not comprehensively evaluate margin status in wide resections. Another study of breast conserving surgery found that re-resection tangential margins represented only 26.8% of the total specimen volume and 32.6% of the specimen surface area. 53 These data suggest that current histologic sectioning techniques may not accurately represent the tumour edge, particularly for marginally excised specimens.
In the authors' experience, sectioning in itself has potential to introduce imprecisions capable of influencing histologic interpretation. 39 Tissues rich in fat commonly disassociate upon sectioning, or are readily distorted (compression/stretching) when transferred into cassettes. Ink can be displaced into locations not representative of the true surgical margin (Fig. 3) . Even when following standard specimen handling recommendations, this problem amy occur at time of ink application, during formalin fixation or in the process of trimming. 
Histologic processing
Tissue processing after formalin fixation might contribute to additional distortion of margins and complicate interpretation. 45 Post-fixation processing typically involves alcohol dehydration with subsequent removal of lipids and other alcohol soluble substances, clearing in a hydrocarbon reagent (e.g. xylene), infiltrating and embedding (usually in paraffin wax), microtomy, and mounting on a slide. 54 Processing related changes in tissue dimensions are not necessarily uniform and might be influenced by the completeness of fixation. 45 During histologic processing, sections of rat liver have as much as a 20% reduction in linear dimension, following minimal shrinkage in formaldehyde solution. 45 A directly relevant study of feline cadaveric skin confirms dramatic dimensional changes between the completion of tissue fixation and generation of an H&E slide. 55 Feline cadaveric skin sample width or length reductions were reported to range from 76 to 85% with a mean of 80%. The average depth (e.g. thickness) of the same samples also increased during histologic processing with a range of 136-226% and a mean of 180%. The latter could be attributed to tissue expansion within the waterbath immediately following microtomy (Fig. 4) . 56 Both the time of immersion and temperature of the water bath might also influence the degree of tissue expansion. 57 Processing imprecisions commonly affect histologic specimens (Fig. 5) although their effect on margin interpretation is less clearly defined. 39 In some instances, minimizing artifacts can be challenging, particularly where section quality is directly impacted by fixation and tissue composition. This is particularly relevant to inadequately fixed tissues, fatty tissues, mammary gland and tissues rich in mineral and/or keratin. 43 ,54,57 Techniques for improving fixation of problematic tissues have been described elsewhere. 43 
Slide evaluation
Beyond the technical challenges of applying margin data to a clinical setting, evaluation of the surgical margin fundamentally relies on a microscopic, morphology-based, interpretation by the pathologist. Significant interpathologist variation has been demonstrated in MCT and STS grading. 58, 59 Variability in pathologists' interpretation regarding vascular invasion as well as absolute margin status has also been demonstrated. 60, 61 By definition, accurate interpretation requires reliable identification of both the tumour edge or infiltrative cells and the surgically incised edge. Although much veterinary literature presents histologic margin status categorically, margin interpretation can carry its own set of challenges and potentials for subjective and inconsistent interpretation. 7, 18, 21, 60, 61 For example, conventional histopathology might not accurately represent margins in tumours with discontinuous growth patterns. 3, 39, 62 Mesenchymal neoplasms, such as feline fibrosarcoma, may be continuous with reactive granulation tissue, making distinction between the neoplastic cells and reactive granulation tissue problematic. 63, 64 In some epithelial tumours, malignant cells that have undergone epithelialmesenchymal transformation might be morphologically indistinguishable from stromal fibroblasts. 65 For canine MCT, differentiating non-neoplastic inflammatory mast cells from well-differentiated neoplastic mast cells at the periphery of the surgical margin remains problematic, although conventional distinction has been based on the presence of cellular clusters. 7, 18, 19 Finally, processing imprecisions may exacerbate these challenges, but the impact has not been elucidated in the peer-reviewed literature (Fig. 5) . 39 
Summary of technical limitations
The relationship between sectioning technique, tumour type, growth pattern and histologic margin interpretation is complex and there is a paucity of evidence-based primary veterinary literature to justify one particular approach. 3 Justifiably, the scientific rationale for basing treatment decisions solely on marginal status in tumours excised with narrow HTFMs is controversial. 7, 14, 18, 66 In addition to resolving the technical limitations of margin examination, multivariate analyses specifically directed at tumour growth pattern might help to address conflicting clinical interpretations. For example, canine subcutaneous MCTs with an infiltrative growth pattern have been linked to increased likelihood of recurrence and decreased patient survival. 67 In human oral SCC, perineural invasion has been associated with negative outcomes, independent of margin status. 68 The extent of margin infiltration might be prognostic in some instances. There is evidence for this concept in human prostatic carcinoma and breast carcinoma. 69 -71 Similarly, in a variety of canine and feline cutaneous malignancies, local recurrence has been shown to be significantly greater in diffusely infiltrated margins compared with focally infiltrated margins (recurrence in 14 of 15 diffusely infiltrated cases compared with 2 of 5 focally infiltrated cases; P = 0.032). 7 In summary, the observation that some tumours fail to recur in the face of residual microscopic disease, while others recur despite apparently complete excision may be partially explained by technical limitations of routine histopathology. It has been proposed that the adequacy of the surgical margin and need for adjuvant therapy is more closely related to the molecular biology of tumour cells at the edge of the invading front, interactions with the stroma and host immune response, than it is to any anatomic factors. 72 Supporting this concept is a growing body of evidence suggesting that the adequacy of excision, and indications for adjuvant therapy, must take into consideration factors related to tumour biology including tumour type, grade and mitotic index. 8, 19, 20, 29 
Biological factors
The concept of molecular margins takes into consideration genetic and/or epigenetic modifications in subpopulations of neoplastic cells. In many instances, molecular signatures might precede phenotypic manifestations of overtly neoplastic cells. 72 -80 As this field develops, molecular margin status might also take into account the tumour microenvironment, now recognized as a hallmark of many cancers. 2 Significant unknowns in tumour biology exist, exemplified by the phenomenon of spontaneous tumour regression wherein a tumour, and potentially the associated distant metastatic lesions, regresses with no residual evidence of disease in the absence of any therapeutic intervention. 81, 82 Conceptual explanations for recurrence, particularly in those tumours where HTFM is greater than zero, are varied. We have chosen to discuss three evolving areas of cancer research, which might partially account for the complex issue of tumour recurrence. Firstly, the field cancerization hypothesis states that morphologically normal cells adjacent to the primary tumour might have already acquired transforming mutations. 83 Recurrence might also be considered in context of tumour heterogeneity, specifically the notion that small subpopulations of cells have potential to dramatically influence the likelihood of either local or distant recurrent disease. 2 In recognition of this concept, it follows that not all incompletely excised tumour cells have the same recurrent potential. Finally, the tumour microenvironment is widely recognized as an active participant in tumourigenesis, and plays a critical role in both invasion and metastasis. 2
Field cancerization
Field cancerization provides one possible explanation for recurrence in tumours where HTFM is greater than zero. Early work by Slaughter et al.
showed that epithelium adjacent to oral SCC may have more than one independent site of malignancy. 83 There are commonalities between genes associated with field cancerization and those associated with cancer stem cell behaviour. 84 In human oral SCC, elevated telomerase activity in the adjacent normal tissue is a marker for tumour recurrence. 85 Loss of heterozygosity can also be demonstrated in the tumour adjacent field in head and neck SCC. 86, 87 Mutations in p53 are commonly identified in the normal tissues adjacent to tumours. 84, 88 One study of human head and neck SCC found that 13 of 25 cases considered completely excised on routine histopathology had molecular evidence of mutated p53 in at least one surgical margin; 5 of these 13 experienced local recurrence. 89 Both the dog and cat have been proposed as naturally occurring models of spontaneous head and neck SCC in humans. Many of the same concepts may be applicable to our veterinary patients, and also provide opportunities for future translational research. 90 
Tumour heterogeneity
Many tumours are a heterogeneous population of cells with varying mutations responsible for different phenotypes. 2, 91 This includes cells with differential capacity for replication, invasion, resistance to hypoxia, metastases, immune evasion and angiogenesis. Phenotypic variation can be further influenced by chemotherapy, radiation therapy and other interventions, which place cancer cells under strong selective pressure. 92 Cancer stem cells (CSCs) and circulating tumour cells (CTCs) in particular have also been linked to recurrence and treatment resistance. 93, 94 Cells resembling CSCs have been demonstrated in lines of canine pulmonary adenocarcinoma and these cells have radioresistant properties. 95 In canine hemangiosarcoma, tumour heterogeneity has been demonstrated in vivo and could represent a mechanism of drug resistance. 96 Tumour heterogeneity considers the possibility that cells at the leading edge of the tumour may have molecular and phenotypic differences from those in the centre. 97, 98 Epithelial-mesenchymal transition (EMT) might contribute to the generation of CSCs, CTCs and dormant cancer cells. 99, 100 Differences in vimentin expression at the invasive front of canine digital SCC have also been described, suggesting EMT may occur at the leading edge of this tumour type. 101 Dormant cancer cells might explain the phenomenon of recurrence following periods of long remission. 100,102 -106 As a stable, non-proliferative state, dormancy is functionally different from senescence which is irreversible. 107 Factors contributing to dormancy include intrinsic or extrinsic cellular mechanisms, limited angiogenesis (angiogenic dormancy) and localized immune effects. 107 A permissive microenvironment is likely to be important for the establishment of disseminated dormant cancer cells. 108 Circulating tumour cells are sparsely distributed in the blood and their concentration may be as low as 1 cell/10 5 -10 7 peripheral blood leukocytes. 109 Although these have been demonstrated in a number of different human cancers, direct evidence of these in veterinary cancers is currently sparse. Potential markers of CTCs from canine mammary carcinomas have been documented. 110 -112 Cancer stem cells have been extensively reviewed elsewhere. 93 
Tumour microenvironment
Recurrent potential may be directly influenced by the tumour microenvironment. The microenvironment could also be critical for the maintenance of CSCs, providing a bed for recipient CTCs, and enabling cancer cell dormancy. 107, 113, 114 Experimentally, alterations in the stromal microenvironment have been linked to recurrence in a mouse model. 115 Characterization of the desmoplastic response is clinically relevant as an independent prognostic factor, associated with the rate of local recurrence in human colorectal carcinoma. 116 Desmoplasia is well recognized in a variety of veterinary malignancies and has also been proposed to carry prognostic relevance; most significantly suggestive of a more malignant phenotype. 117 -124 Therapeutic interventions in themselves are capable of influencing the tumour microenvironment and potentiating the risk of recurrence. Radiotherapy modifies tumour vascularity, stroma and local immunity. 125 Surgery can be associated with perioperative increases in inflammatory mediators such as VEGF, IL-6, TNF-and reactive oxygen species which may modify the local tumour environment, leading to alterations in tumour behaviour. 126, 127 Localized tumour inflammation modifies the local tumour microenvironment, including the invasive potential of cancer cells. 2 Inflammatory mediators known to promote tumourigenesis include EGF, VEGF, FGF-2 and matrix metalloproteinases. 128 Immune responses, such infiltration of IL-17(+) cells can independently influence local recurrence in human cervical cancer. 129 
Future directions
Predicting the likelihood of recurrence and determining the adequacy of a surgical margin will likely require a multifaceted approach. Specifically, future research might aim to refine existing techniques and utilize novel approaches that take into account tumour molecular biology. Here, we will focus on strategies that enable early detection of recurrent disease (e.g. prior to grossly visible regrowth), ameliorate limitations of routine histopathology, and leverage an evolving understanding of cancer biology.
Detection of recurrence
Recurrence in the veterinary literature has been primarily defined by the presence of macroscopic disease. 7, 19, 20 For those tumours that regrow slowly (e.g. low grade canine STS), clinical detection of macroscopic recurrent disease may be a late and relatively insensitive endpoint. Earlier clinical detection of recurrence could help establish the validity of alternative strategies that seek to determine adequacy of surgical excision. In humans, biochemical markers can detect early recurrence in prostatic carcinoma, hepatocellular carcinoma, lung cancer, cervical cancer and ovarian cancer. 130 -134 Biochemical recurrence has also been explored in canine lymphoma. 135 -139 Hairpin-shaped, clone specific primers have been used to detect minimal residual disease in dogs with complete remission of B cell lymphoma. 140 Although lymphoma is generally not a surgical condition, these examples demonstrate the potential for biomarkers in detecting recurrence prior to visible macroscopic disease. These same methods might also be utilized to determine residual disease following curative-intent treatment.
Alternative strategies to conventional histopathology
Alternative and/or complimentary methods of margin evaluation may offer opportunities to mitigate some of the technical limitations of conventional histologic techniques. For example, touch-prep cytology of surgical margins has been described in human breast cancer and has the added benefit of offering intra-operative assessment of margin status with very high sensitivity and specificity. 141 -143 The accuracy of touch-prep margin cytology, however, may vary depending on the tumour type and propensity for neoplastic cells to exfoliate. If results of touch-prep margin cytology were to be used intra-operatively for surgical decision-making (e.g. additional margin resection required or not), availability of appropriate clinical pathology personnel would need to be coordinated (i.e. a 'STAT' procedure). Shaved margin samples can be taken by the surgeon at the time of tumour resection either from the resected specimen or from the resultant surgical wound bed prior to closure. These samples focus the pathologist's attention on specific areas of concern for residual tumour while reducing susceptibility to problems such as post-excision surgical margin folding, distortion and loss of orientation. 46 In human head and neck cancer, a multimodal imaging technique is being developed to allow identification of premalignant tissues in real-time during tumour resections. 80 Another study using a murine soft tissue sarcoma model applied topical nucleic acid-binding stains to the surgical bed that allowed in vivo visualization of residual microscopic disease using fluorescence microscopy. 147 In that study, improved sensitivity for predicting recurrence compared to standard pathology was documented (78 versus 29%, respectively). Two recent veterinary publications have used a near-infrared fluorescent probe that is preferentially activated within neoplastic cells (due to an over-expression of cathepsin proteases in the tumour) to assess the surgical wound bed for residual tumour at the time of surgery. 79, 148 Data from these preliminary studies suggests this method of margin assessment has good correlation with histology (92% sensitivity and 92% specificity) and holds promise for guiding surgical resection of locally invasive malignancies. 148 
Strategies that leverage an evolving knowledge of tumour biology
Tumour-specific molecular signatures could be used to develop a more sophisticated approach to surgical margins. Canine MCT with internal tandem duplications in exons 11 and 12 of KIT have been linked to tumour grade and possibly recurrent potential. 149 Using multivariable analysis, another group has confirmed that dogs with internal tandem duplications in exon 11 of KIT are at significant risk of local recurrence. 150 An improved understanding of molecular oncogenesis may continue to influence local recurrence risk in other veterinary tumours.
In human medicine, where tumour-specific molecular signatures are more clearly defined, there are many examples that demonstrate an association with recurrent potential. Human stage II gastric cancer, which has a 25-40% recurrence rate, can be substratified into risk categories according to expression of eight genes. 151 MicroRNAs (miRNAs) are emerging cancer biomarkers and there is some evidence suggesting that these might be used to predict local recurrence. Expression of four prognostic miRNA signatures predicts recurrence independently from other clinical factors in human oral SCC. 152 miRNA-9 has been linked to local recurrence in oestrogen-receptor positive breast cancers. 153 Other epigenetic changes, such as global histone modifications have also been used to predict risk of recurrence in human prostate cancer. 154 Long noncoding RNA profiles have been used to predict recurrence in adrenocortical cancer. 155 Other targets evaluated for surgical margin assessment include proto-oncogenes, microsatellite instability, chromosomal loss of heterogeneity, cancer stem cell markers, tumour antigens and tumour-associated gene mutations. 72,156 -159 Some molecular markers have relied upon identification of epigenetic alterations in the surgical margin itself (as opposed to the tumour). For example, DAPK promoter DNA hypermethylation in histologically negative surgical margins from human oral SCC was detected frequently and found to be an independent prognostic factor for decreased overall survival. 160 Current identification of specific molecular markers (or panels of markers) with clinical prognostic significance might be limited by individual tumour-and patient-specificity. 161 Although there is a paucity of literature that is directly applicable to veterinary molecular margins, close parallels between human and canine cancers suggest that these concepts might also be applicable to veterinary patients. 162 
